In the current study, we showed that, for CRC cells, less EGFR phosphorylation upon TRIP13 knockdown, suggesting that the binding of TRIP13 to EGFR is disrupted, thus resulting in less phosphorylation and leading to suppression of the EGFR signaling pathway. The gene discussed is EGFR; the disease is colorectal carcinoma.